TMCnet9m
Gradalis Announces Development of Clinically Relevant Exome Sequencing Bioinformatics Pipeline to Determine Clonal Tumor Mutation Burden
Vigil is the first cellular immunotherapy to demonstrate longer-term survival benefits in a randomized controlled trial of patients with solid tumors. The results of the company’s Phase 2b study have ...
The Brighterside of News on MSN53m
Secrets of the Greenland Shark’s Longevity Revealed in New Study
The Greenland shark, a slow-moving giant of the North Atlantic and Arctic Oceans, holds the record as the longest-lived ...